T-Cells Mediate an Inhibitory Effect of Interleukin-4 on Osteoclastogenesis

Journal of Bone and Mineral Research

Volumn 18, Issue 6, 2003, Pages 984-993

  Mirosavljevic, Danijela ^a   Quinn, Julian M W ^a   Elliott, Jan ^a   Horwood, Nicole J ^a   Martin, T John ^a   Gillespie, Matthew T ^a  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Co culture; Interleukin 4; Lymphocyte; Osteoclast; RANKL

Indexed keywords

CELL ANTIGEN; COLONY STIMULATING FACTOR 1; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOCLAST INHIBITORY LECTIN; OSTEOPROTEGERIN; THYMIC SHARED ANTIGEN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL ADHESION; CELL SEPARATION; CONTROLLED STUDY; MACROPHAGE; MALE; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; OSTEOCLAST; SPLEEN CELL; STEM CELL; T LYMPHOCYTE; TH2 CELL; WILD TYPE;

ANIMALS; BASE SEQUENCE; CARRIER PROTEINS; CELL LINE; DNA PRIMERS; INTERLEUKIN-4; LYMPHOCYTE DEPLETION; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOCLASTS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; T-LYMPHOCYTES; TH2 CELLS;

EID: 0142091199     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2003.18.6.984     Document Type: Article

References (46)

1. Lacey DL, Timms E, Tan H-L, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian Y-X, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ 1998 Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176.
2. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602.
3. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ 1997 Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309-319.
4. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM 1999 OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323.
5. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L 1997 A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175-179.
6. Horwood NJ, Kartsogiannis V, Quinn JM, Romas E, Martin TJ, Gillespie MT 1999 Activated T-lymphocytes support osteoclast formation in vitro. Biochem Biophys Res Commun 265:144-150.
7. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM 1999 Activated T-cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402:304-309.
8. Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, Nakamura K, Taniguchi T 2000 T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 408:600-605.
9. Horwood NJ, Udagawa N, Elliott J, Grail D, Okamura H, Kurimoto M, Dunn AR, Martin T, Gillespie MT 1998 Interleukin 18 inhibits osteoclast formation via T-cell production of granulocyte macrophage colony-stimulating factor. J Clin Invest 101:595-603.
10. Shioi A, Teitelbaum SL, Ross FP, Welgus HG, Suzuki H, Ohara J, Lacey DL 1991 Interleukin 4 inhibits murine osteoclast formation in vitro. J Cell Biochem 47:272-277.
11. Riancho JA, Zarrabeitia MT, Gonzalez-Macias J 1993 Interleukin-4 modulates osteoclast differentiation and inhibits the formation of resorption pits in mouse osteoclast cultures. Biochem Biophys Res Commun 196:678-685.
12. Nakano Y, Watanabe K, Morimoto I, Okada Y, Ura K, Sato K, Kasono K, Nakamura T, Eto S 1994 Interleukin-4 inhibits spontaneous and parathyroid hormone-related protein-stimulated osteoclast formation in mice. J Bone Miner Res 9:1533-1539.
13. Lubberts E, Joosten LA, Chabaud M, van Den Bersselaar L, Oppers B, Coenen-De Roo CJ, Richards CD, Miossec P, van Den Berg WB 2000 IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion. J Clin Invest 105:1697-1710.
14. Abu-Amer Y 2001 IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-kappaB. J Clin Invest 107:1375-1385.
15. Bendixen AC, Shevde NK, Dienger KM, Willson TM, Funk CD, Pike JW 2001 IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1. Proc Natl Acad Sci USA 98:2443-2448.
16. Onoe Y, Miyaura C, Kaminakayashiki T, Nagai Y, Noguchi K, Chen QR, Seo H, Ohta H, Nozawa S, Kudo I, Suda T 1996 IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts. J Immunol 156:758-764.
17. Horwood NJ, Elliott J, Martin TJ, Gillespie MT 2001 IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro. J Immunol 166:4915-4921.
18. Noben-Trauth N, Shultz LD, Brombacher F, Urban JF Jr, Gu H, Paul WE 1997 An interleukin 4 (IL-4)-independent pathway for CD4+ T-cell IL-4 production is revealed in IL-4 receptor-deficient mice. Proc Natl Acad Sci USA 94:10838-10843.
19. Kagi D, Ledermann B, Burki K, Seiler P, Odermatt B, Olsen KJ, Podack ER, Zinkernagel RM, Hengartner H 1994 Cytotoxicity mediated by T-cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31-37.
20. Spanopoulou E, Roman CA, Corcoran LM, Schlissel MS, Silver DP, Nemazee D, Nussenzweig MC, Shinton SA, Hardy RR, Baltimore D 1994 Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice. Genes Dev 8:1030-1042.
21. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S 1994 Generalized lymphoproliferative disease in mice caused by a point mutation in the Fas ligand. Cell 76:969-976.
22. Nicholson GC, Moseley JM, Sexton PM, Mendelsohn FA, Martin TJ 1986 Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization. J Clin Invest 78:355-360.
23. Zammit DJ, Berzins SP, Gill JW, Randle-Barrett ES, Barnett L, Koentgen F, Lambert GW, Harvey RP, Boyd RL, Classon BJ 2002 Essential role for the lymphostromal plasma membrane Ly-6 superfamily molecule thymic shared antigen 1 in development of the embryonic adrenal gland. Mol Cell Biol 22:946-952.
24. Udagawa N, Horwood NJ, Elliott J, Mackay A, Owens J, Okamura H, Kurimoto M, Chambers TJ, Martin TJ, Gillespie MT 1997 Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation. J Exp Med 185:1005-1012.
25. Quinn JM, Elliott J, Gillespie MT, Martin TJ 1998 A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology 139:4424-4427.
26. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE 1992 RAG-1-deficient mice have no mature B and T-lymphocytes. Cell 68:869-877.
27. McInnes A, Rennick DM 1988 Interleukin 4 induces cultured monocytes/macrophages to form giant multinucleated cells. J Exp Med 167:598-611.
28. McNally AK, Anderson JM 1995 Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated gianT-cells. Am J Pathol 147:1487-1499.
29. Ikeda T, Ikeda K, Sasaki K, Kawakami K, Hatake K, Kaji Y, Norimatsu H, Harada M, Takahara J 1998 IL-13 as well as IL-4 induces monocytes/macrophages and a monoblastic cell line (UG3) to differentiate into multinucleated gianT-cells in the presence of M-CSF. Biochem Biophys Res Commun 253:265-272.
30. Zhou H, Kartsogiannis V, Hu YS, Elliott J, Quinn JM, McKinstry WJ, Gillespie MT, Ng KW 2001 A novel osteoblast-derived C-type lectin that inhibits osteoclast formation. J Biol Chem 276:14916-14923.
31. Choi SJ, Devlin RD, Menaa C, Chung H, Roodman GD, Reddy SV 1998 Cloning and identification of human Sca as a novel inhibitor of osteoclast formation and bone resorption. J Clin Invest 102:1360-1368.
32. Renz H, Domenico J, Gelfand EW 1991 IL-4-dependent up-regulation of IL-4 receptor expression in murine T and B-cells. J Immunol 146:3049-3055.
33. Howard M, Farrar J, Hilfiker M, Johnson B, Takatsu K, Hamaoka T, Paul WE 1982 Identification of a T-cell-derived B-cell growth factor distinct from interleukin 2. J Exp Med 155:914-923.
34. Hu-Li J, Shevach EM, Mizuguchi J, Ohara J, Mosmann T, Paul WE 1987 B-cell stimulatory factor 1 (interleukin 4) is a potent costimulant for normal resting T-lymphocytes. J Exp Med 165:157-172.
35. Kasono K, Sato K, Sato Y, Tsushima T, Shizume K, Demura H 1993 Inhibitory effect of interleukin-4 on osteoclast-like cell formation in mouse bone marrow culture. Bone Miner 21:179-188.
36. Lacey DL, Erdmann JM, Tan HL, Ohara J 1993 Murine osteoblast interleukin 4 receptor expression: Upregulation by 1, 25 dihydroxyvitamin D3. J Cell Biochem 53:122-134.
37. Choi SJ, Reddy SV, Devlin RD, Menaa C, Chung H, Boyce BF, Roodman GD 1999 Identification of human asparaginyl endopeptidase (legumain) as an inhibitor of osteoclast formation and bone resorption. J Biol Chem 274:27747-27753.
38. Choi SJ, Kurihara N, Oba Y, Roodman GD 2001 Osteoclast inhibitory peptide 2 inhibits osteoclast formation via its C-terminal fragment. J Bone Miner Res 16:1804-1811.
39. Lewis DB, Liggitt HD, Effmann EL, Motley ST, Teitelbaum SL, Jepsen KJ, Goldstein SA, Bonadio J, Carpenter J, Perlmutter RM 1993 Osteoporosis induced in mice by overproduction of interleukin 4. Proc Natl Acad Sci USA 90:11618-11622.
40. Burgess TL, Qian Y, Kaufman S, Ring BD, Van G, Capparelli C, Kelley M, Hsu H, Boyle WJ, Dunstan CR, Hu S, Lacey DL 1999 The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J Cell Biol 145:527-538.
41. van't Hof RJ, Ralston SH 1997 Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity. J Bone Miner Res 12:1797-1804.
42. Holliday LS, Dean AD, Lin RH, Greenwald JE, Gluck SL 1997 Low NO concentrations inhibit osteoclast formation in mouse marrow cultures by cGMP-dependent mechanism. Am J Physiol 272:F283-F291.
43. Chen B, Keshive M, Deen WM 1998 Diffusion and reaction of nitric oxide in suspension cell cultures. Biophys J 75:745-754.
44. Nemoto Y, Otsuka T, Niiro H, Izuhara K, Yamaoka K, Nakashima H, Niho Y 1999 Differential effects of interleukin-4 and interleukin-10 on nitric oxide production by murine macrophages. Inflamm Res 48:643-650.
45. Sands WA, Bulut V, Severn A, Xu D, Liew FY 1994 Inhibition of nitric oxide synthesis by interleukin-4 may involve inhibiting the activation of protein kinase C epsilon. Eur J Immunol 24:2345-2350.
46. al-Ramadi BK, Meissler JJ Jr, Huang D, Eisenstein TK 1992 Immunosuppression induced by nitric oxide and its inhibition by interleukin-4. Eur J Immunol 22:2249-2254.